Want to join the conversation?
Investment management company $IVZ reported a drop in 1Q16 earnings due to lower investment management fees and fall in service and distribution fees as well lower performance fees. Net income slid to $161MM or $0.38 per share from $259.6MM or $0.60 per share last year. Operating revenues fell 11.1% to $1.15Bil. Adjusted EPS fell 22.8% to $0.49.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.